Innate Pharma to Participate in Upcoming Investor Conferences

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences:  

  • September 07, 2021 - Goldman Sachs 11th Annual Biotech Symposium
  • September 08-09, 2021 - Citi 16th Annual Biopharma Virtual Conference
  • September 13, 2021 - H.C.Wainwright 23rd Annual Global Investment Conference